The Biosensing team relies on the expertise of Dr David Sarphie and Prof. Tony Cass. We specialise in the development of portable sensors and we are currently developing a quantitative test for the diagnosis and monitoring of kidney disease (QELFA) and an innovative device for the monitoring of arsenic contamination (drinksafe). In the past, we have provided technical consultancy for development of a point-of-care diagnostics product and prototyped a bench-top instrument for label-free biosensing.
